During 2005, seven of the top ten licensing or co-development deals (in terms of potential value) involved one of the five companies featured in PharmaVentures' recently published series of PharmaDeals#174; Deal Making Spotlight Reports. These reports detail the deal making activities of Pfizer, GlaxoSmithKline, sanofi-aventis, Johnson & Johnson and Novartis in the period 2000-2005, and are supported by a concise breakdown of each company's deal making trends, produced by PharmaVentures' Business Analysts. In addition, limited online access to PharmaDeals#174; Agreements is provided with each report, which enables the reader to track the progress of individual deals. This article highlights the main features of the reports.